Treace Medical Concepts, Inc.

NasdaqGS TMCI

Treace Medical Concepts, Inc. Market Capitalization on January 14, 2025: USD 499.00 M

Treace Medical Concepts, Inc. Market Capitalization is USD 499.00 M on January 14, 2025, a -35.47% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Treace Medical Concepts, Inc. 52-week high Market Capitalization is USD 981.10 M on February 12, 2024, which is 96.61% above the current Market Capitalization.
  • Treace Medical Concepts, Inc. 52-week low Market Capitalization is USD 257.96 M on May 08, 2024, which is -48.31% below the current Market Capitalization.
  • Treace Medical Concepts, Inc. average Market Capitalization for the last 52 weeks is USD 521.45 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqGS: TMCI

Treace Medical Concepts, Inc.

CEO Mr. John T. Treace
IPO Date April 23, 2021
Location United States
Headquarters 203 Fort Wade Road
Employees 516
Sector Health Care
Industries
Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Similar companies

FNA

Paragon 28, Inc.

USD 10.28

-4.28%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SGHT

Sight Sciences, Inc.

USD 3.15

-2.78%

AXGN

AxoGen, Inc.

USD 18.24

-0.06%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

CNMD

CONMED Corporation

USD 67.79

-2.46%

LIVN

LivaNova PLC

USD 47.63

0.66%

IRMD

IRadimed Corporation

USD 57.52

1.79%

TCMD

Tactile Systems Technology, Inc.

USD 17.46

1.51%

ESTA

Establishment Labs Holdings Inc.

USD 33.15

-1.66%

ITGR

Integer Holdings Corporation

USD 138.83

2.72%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

RXST

RxSight, Inc.

USD 30.08

-2.08%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email